Publications & Videos

Last update: 10/5/2021

English

Effect of an ionic antineoplastic agent Cytoreg on blood chemistry in a Wistar rat model
Katiusca Villasana, William Quintero, Yepsys Montero, Cristian Pino, Oscar Uzcategui, Geizon Torres, Mariangel Prada, Lewis Pozo, William Bauta, William Jimenez

Evaluation of dermal corrosion and irritation by Cytoreg® in rabbits
William Jimenez, Eduardo Gonzalez, Vincent A. Murphy and William Bauta

Chronic Toxicity in Wistar Rats of Cytoreg, An Ionic Antineoplastic Therapeutic Mix of Strong and Weak Acids.
Rosa De Jesús*, Nelson Vicuña-Fernández, Andrés Osorio, David Martucci, Lewis Pozo, Carlos M. García, William Jiménez

In vivo effectiveness tests of the Cytoreg® formulation against melanoma B16F1 in female mice C57BL/6/BIOU
Rosa De Jesús*, Nelson Vicuña-Fernández, Andrés Osorio, Marie Cuervo, David Martucci, Lewis Pozo, William Jiménez

Histological study of Melanoma B16F1 inoculated in C57BL/6/BIOU female mice with the formulation Cytoreg®,
Rosa De Jesús*, Nelson Vicuña-Fernández, Andrés Osorio, Marie Cuervo, David Martucci, Lewis Pozo, William Jiménez.

Determination of medium lethal dose (LD50) and acute toxicity of formulation Cytoreg®, an ionic mixture of strong and weak acids.
Rosa De Jesus*, Nelson Vicuña-Fernández, Andrés Osorio, David Martucci, Lewis Pozo, William Jimenez

Therapeutic efficacy of Genistein-Cytoreg® combination in breast cancer cells.
Johnson MM*, Kumi-Diaka KJ, Zoeller R, Graves BS, Merchant KT,  Hörmann VP, and Hassanhi M

Cytoreg® inhibits growth and proliferation of human adenocarcinoma cells via induction of apoptosis.
J Kumi-Diaka*, M Hassanhi*, J Brown, K Merchant, C Garcia, W Jimenez

Español

Pruebas de efectividad in vivo de la formulación Cytoreg® contra el melanoma B16F1 en ratones hembras C57BL/6//BIO
Rosa De Jesús*, Nelson Vicuña-Fernández, Andrés Osorio, Marie Cuervo, David Martucci, Lewis Pozo, William Jiménez

Estudio de la toxicidad crónica en conejas administrando la formulación Cytoreg®
De Jesús, Rosa*; Vicuña-Fernández, Nelson; Romel Molina; Martucci, David; Pozo, Lewis; Jiménez, William

Histología del melanoma B16F1 en ratones inoculados y tratados con Cytoreg
Rosa De Jesús*, Marie Cuervo, Nelson Vicuña-Fernández, Andrés Osorio, Domingo Stea, David Martucci,Lewis Pozo, William Jiménez

Presented Posters

Evaluation of the Efficacy of the Therapeutic Agent Cytoreg in Patients with Diabetic Foot: A Clinical Humanitarian Protocol
Dario A. Carrillo, Katiusca Villasana, Geizon Torres, Lewis J. Pozo, William J. Jimenez, William E. Bauta and Leonardo Dugarte Sr.

Evaluation of a Novel Anti-Tumor Drug Using In Vitro Toxicity Screening in Rat Hepatoma (H4IIE) Cells, Normal Rat Kidney (NRK) Cells, and Rat Primary Hepatocytes
Paul C. Wilga, James M. McKim, Jr., Jeffrey F. Pregenzer, Diane K. Petrella, and Ariel J. Swanson

Effect of Cytoreg® on Biomarkers in B16-F10 Murine Melanoma
Elzbieta Izbicka*, Manzur S. Hassanhi,

Determinación de dosis letal media (DL50) y toxicidad aguda de la formulación CK (Cytoreg®), una mezcla Iónica de ácidos fuertes y débiles
Rosa De Jesús, Nelson Vicuña-Fernández,, Andrés Osorio,, David Martucci, Lewis Pozo, William Jiménez

Scientific Videos

Cytoreg® inhibits Astrocytoma cell migration at high dilution in absence of cell death